Karhapaa P, Uusitupa M, Voutilainen E, Laakso M (1992) Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia
FDA 503B refers to Section 503B of the Food, Drug, and Cosmetic Act (FD&C Act)
Main symptoms are hyperammonemia, metabolic acidosis, hypoketotic hypoglycemia with elevated creatine kinase and reduced carnitine levels [18]
Many women breastfeed for 12 months or longer
Modern medicine recognises obesity as a chronic, relapsing health condition that often benefits from long-term, integrated medical care rather than short-term fixes or unsupervised approaches
Once you achieve the result, it will remain forever until you expose too much to UV rays and pollutants